基本資料
種類: ETF
費用比率%: 0.79
資產淨值: 84.25
成立日期: 16/12/2014
 
分析
市值分佈:
64.52%
大市值
25.61%
中市值
8.26%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/11/2026 05:47) 總持有投資項目: 65  
0%
 
100%
     10大 (26.00%)
代號 名稱 佔比% ▼ 持有日期
TGTXTG Therapeutics1.6030/10/2026
ROIVRoivant Sciences Ltd1.5930/10/2026
SRPTSarepta Therapeutics1.5730/10/2026
ADMAADMA Biologics1.5730/09/2026
TARSTarsus Pharmaceuticals1.5630/10/2026
NVAXNovavax1.5630/09/2026
GILDGilead Sciences1.5230/09/2026
IBRXImmunityBio1.5130/10/2026
INSMInsmed Incorporated1.4930/10/2026
KURAKura Oncology1.4730/10/2026
HRMYHarmony Biosciences Holdings1.4630/09/2026
BBIOBridgeBio Pharma1.4530/10/2026
INCYIncyte Corp1.4330/10/2026
CRSPCRISPR Therapeutics AG1.4230/09/2026
UTHRUnited Therapeutics Corp1.4230/10/2026
IRWDIronwood Pharmaceuticals1.3930/09/2026
IMCRImmunocore Holdings plc1.3630/10/2026
AUPHAurinia Pharmaceuticals1.3630/10/2026
RYTMRhythm Pharmaceuticals1.3530/10/2026
BMRNBioMarin Pharmaceutical1.3530/10/2026
  1   2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.